is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Cipla Limited required for business and competitor intelligence needs
A study of the major internal and external factors affecting Cipla Limited in the form of a SWOT analysis
An in-depth view of the business model of Cipla Limited including a breakdown and examination of key business segments
Intelligence on Cipla Limited’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Cipla Limited, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Cipla (or 'the company') is an India-based manufacturer of prescription drugs, formulations and veterinary products. It is headquartered in Mumbai, India, and employs more than 20,000 people. The company recorded revenues of INR101,003.9 million (approximately $1,676.7 million) during the financial year ended March 2014 (FY2014), an increase of 22% over FY2013. The operating profit* of the company was INR18,800.4 million (approximately $312.1 million) in FY2014, a decrease of 8.5% compared with FY2013. The net profit of the company was INR13,884.1 million (approximately $230.5 million) in FY2014, a decrease of 10.1% compared with FY2013. *Earnings before interest and tax.
Reasons to Purchase:
Gain understanding of Cipla Limited and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Cipla Limited as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Cipla Limited’s business structure, strategy and prospects